The current price of TRNS is $101.51 — it has increased by 1.13% since the previous close. Data as of Nov 6, 2026.
TRNS is up 16.24% over the past week, up 14.33% over the past month and up 83.40% over the past year. The price is above its 200-day moving average of $82.51.
Analysts' average 12-month price target for TRNS is $115.00, which implies 13.29% upside from the current price. Individual estimates range from $115.00 to $115.00.
Of the 5 analysts covering Transcat, Inc., 1 rates it a strong buy, 3 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Transcat, Inc. has a market capitalization of $950.11M. The company belongs to the Industrials sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Transcat, Inc. posted earnings of $0.64 per share against an estimate of $0.448, beating expectations by 42.86%. Upcoming reports are listed in the earnings calendar.
Transcat, Inc. reported revenue of $97.09M in its most recent quarter, which has increased by 18.01% compared with the same quarter a year earlier. Analysts had expected $92.46M.
Transcat, Inc. has not paid any dividends over the past year.
Companies most comparable to Transcat, Inc. include Mettler-Toledo International Inc., Bio-Techne Corporation, Bio-Rad Laboratories, Inc., UFP Technologies, Inc. and TIC Solutions, Inc.
In the latest trading session TRNS moved between $100.59 and $103.26, a range of 2.63% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Transcat, Inc. shows a buy rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks TRNS has traded between $50.23 and $110.47. The current price is 8.11% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.